.
BUDGET 2012
 | News | Market | Portfolio | Messages
SENSEX
27715.83 369.50 (1.35%)
NIFTY
8277.20 108.00 (1.32%)
Go to Moneycontrol Home
Pharmaceuticals
Biocon Q2 net flat at Rs 102 crore on higher expenses
Consolidated total income from operations of Biocon rose to Rs 757.59 crore for the quarter under consideration as again
Alembic Pharma expects API biz to grow 10% in FY15
Alembic Pharmaceuticals Q2 profit up 25% at Rs 77.3 cr
Indoco Remedies Q2 net profit up 40% at Rs 22.4 cr
STOCK RECOMMENDATION
Stock Advice
Buy Divis Laboratories, advises Sudarahan Sukhani
Accumulate Dr Reddy's Laboratories: Phani Sekhar
Sell Biocon, says Kunal Bothra
more
Broker Reports
Buy Nectar Lifesciences; tgt of Rs 46: Firstcall Research
Accumulate Biocon; target of Rs 536: Dolat Capital
Buy Arvind Remedies; target of Rs 100: Ventura
more
Budget 2012
HOME
Font Size: S M L
Mobile | Classic
Customer Support
© 2011. a Web18 Venture